Ursodeoxycholic Acid Market Poised for Substantial Growth Owing to Wide Range of Therapeutic Applications

Ursodeoxycholic acid is a natural bile acid produced by the liver that is used to dissolve gallstones and treat liver diseases. It acts as an anti-fibrotic by reducing liver inflammation and scarring. Ursodeoxycholic acid supplements improve liver function in conditions like Primary Biliary Cholangitis (PBC), a chronic autoimmune disease that damages the bile ducts in the liver. It helps promote bile flow, reduces itching symptoms, and improves blood tests in PBC patients.

The global ursodeoxycholic acid market is estimated to be valued at US$ 640.45 Mn in 2023 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Dynamics:
One of the key drivers for the growth of the ursodeoxycholic acid market is its wide range of therapeutic applications such as treatment of liver diseases like PBC and gallstone dissolution. Ursodeoxycholic acid suppresses the formation of cholesterol gallstones and helps eliminate existing gallstones. It acts as a hydrophilic bile acid that replaces more hydrophobic bile acids and improves bile flow and liver functions. Additionally, increased R&D spending by key players for developing novel ursodeoxycholic acid formulations is also fueling market growth. For instance, in 2019, Dr. Falk Pharma GmbH received approval from the European Commission for ursodeoxycholic acid tablets indicated for treatment of PBC in adults.

SWOT Analysis
Strength: Ursodeoxycholic acid is primarily used for the treatment of primary biliary cholangitis and fremont cholecystitis. It helps dissolve bile in the gallbladder and improve liver function. Furthermore, increasing awareness about primary biliary cholangitis and its treatment will drive the demand for ursodeoxycholic acid.

Weakness: The production of ursodeoxycholic acid involves complex chemical processes and purification methods. This increases its production cost. Moreover, alternative treatments are being studied which can limit the overall market growth of ursodeoxycholic acid.

Opportunity: The rising prevalence of obesity and metabolic disorders will increase the risk of gallstones formation which in turn will boost the demand for ursodeoxycholic acid. Moreover, new drug delivery methods are being researched to enhance its efficacy and reduce dosage which can capture more market share.

Threats: Stringent regulations governing the drug approval process can hamper market growth. Additionally, side effects associated with long term use like diarrhea can limit its adoption. Alternative treatments developed can pose strong competition.

Key Takeaways
he Global Ursodeoxycholic Acid Market Size is expected to witness high growth. The global Ursodeoxycholic Acid Market is estimated to be valued at US$ 640.45 Mn in 2023 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030.

North America dominates the global market and is expected to continue its dominance during the forecast period. This is attributed to increasing incidence of gallbladder and liver diseases. Additionally, presence of major manufacturers in the region will propel market growth.

Europe is the second largest market and is expected to register strong growth due to growing awareness regarding biliary diseases and related treatment. Asia Pacific shows lucrative growth opportunities owing to rising healthcare expenditure, increasing patient pool suffering from obesity and growing medical tourism in countries like India, China and Japan.

Key players operating in the Ursodeoxycholic acid market are Fender Musical Instruments Corporation, Gibson Brands, Ernie Ball Inc., GHS Strings, C. F. Martin & Company Inc., Dunlop Manufacturing, Inc., Dean Markley USA, Inc., Kistron Co., Ltd., Rotosound Manufacturing Ltd., and DR Handmade Strings. Major players are focusing on new drug delivery methods and strengthening their distribution networks across regions to consolidate market presence.

 

Get more insights on this topic:
https://www.rapidwebwire.com/ursodeoxycholic-acid-market/

Comments

Post a Comment

Popular posts from this blog

Vegan Yogurt Market is Poised for Growth Driven by Rising Health Consciousness

Image
Vegan yogurt is a dairy-free alternative to conventional yogurt made from plant-based milk such as soy, almond, oat, coconut or rice. It provides similar texture and taste to dairy yogurt but without any animal products.Vegan yogurt offers several health advantages over dairy yogurt as it is devoid of lactose, cholesterol and saturated fats. The growing number of people adopting vegan and flexitarian diets has driven the demand for plant-based dairy alternatives like vegan yogurt. The global vegan yogurt market is estimated to be valued at US$ 4.15 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031. Key Takeaways Key players- Met Fods, Cocos Organic, Hain Celestial, EasiYo Product Limited, Danone, General Mills Inc., Stonyfield Far, Inc., Daiya Foods Inc.m Good Karma foods, Inc.m Hudson River Foodsm NANCY'S, Kite Hill, COYO Pty lTd., Nush Foods, Chobani, LLC, Barambah Oraganics Pty Ltd., Blue Diamond Growers, Dean Foodsm General Mills Inc...
Read more

Hypoglycemic Drugs Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes in the Geriatric Population

Image
Hypoglycemic drugs or anti-diabetic drugs are medications used to treat diabetes mellitus by lowering blood glucose levels. Some key hypoglycemic drugs include insulin, sulfonylureas, metformin, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and GLP-1 receptor agonists. These drugs help control blood sugar levels in diabetics and prevent or delay diabetes-related health complications. The global hypoglycemic drugs market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The growth of the global hypoglycemic drugs market is majorly driven by the increasing prevalence of diabetes in the geriatric population globally. As per estimates, around 1 in every 11 people aged 65 years and above have diabetes. Further, the number of people with diabetes in this age group is anticipated to grow from 25.9 million in 2017 to...
Read more

Clinical Trials Rising with Digital Technologies Adoption

Image
 Clinical trials support services play a vital role in assisting sponsors and life science companies to conduct clinical trials in a precise and well-organized manner.These services assist pharmaceutical companies in patient recruitment, data management, site management, and overall clinical trial management. With rising complexities in clinical trials owing to integration of technologies like telehealth and remote patient monitoring, the demand for these support services is growing substantially. The global Clinical Trials Support Services Market is estimated to be valued at US$ 22.38 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing adoption of digital technologies across clinical trials is a key trend accelerating the growth of the clinical trials support services market. Digital tools like electronic data capture, clinical trial manag...
Read more